Michael G. Agadjanyan
7Patents
2h-index
5Co-inventors
40Inventor score
Filing activity: Apr 27, 2000 → Jul 12, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8202847B2 | Mutant human CD80 and compositions for and methods of making and using the same | Human Necessities | 11 | Active |
| US7446189B1 | Nucleic acids encoding mutant human CD80 and compositions comprising the same | Human Necessities | 8 | Expired |
| US10570196B2 | Humanized anti-tau antibodies and compositions for and methods of making and using in treatment, diagnosis and monitoring of tauopathies | Chemistry; Metallurgy | 2 | Active |
| US10005825B2 | Compositions and methods related to diseases associated with deposits of amyloid, tau, and alpha-synuclein | Chemistry; Metallurgy | 1 | Active |
| US7943587B2 | Vaccines and gene therapy compositions and methods of making and using the same | Chemistry; Metallurgy | 0 | Expired |
| US8114405B2 | Cancer vaccine based on brother of regulator of imprinted sites molecule (BORIS) | Human Necessities | 0 | Active |
| US7579452B2 | Cancer vaccine based on brother of regulator of imprinted sites molecule | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.